Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-09

Clinical Trial Update: Type 1 Interferon Induced Changes to Exercise Adaptations in Systemic Lupus Erythematosus Patients [NA]

View source ↗

Summary

This clinical trial update reports a completed study examining the effects of Type I Interferon on exercise adaptations in patients with systemic lupus erythema…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Type I Interferon (Interferon type I)

Snippet

Sponsor: Rigshospitalet, Denmark | Conditions: Systemic Lupus Erythematosus, Interferon Deficiency | NA | Status: COMPLETED